SAPIENT CAPITAL LLC

Position in EXEL — Exelixis, Inc.

CIK 1998653 INDIANAPOLIS, IN

Position in EXEL

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$307,851

+$71,956 QoQ

Shares Held

5,658

+2.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#22

of 47 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

SAPIENT CAPITAL LLC holds $34,121,163 across 5 Biotechnology names. EXEL ranks #3 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	92,162	$24,581,448
2	VRTX	Vertex Pharmaceuticals Inc / Ma	18,011	$8,946,604
3	EXEL	Exelixis, Inc. This page	5,658	$307,851
4	NUVB	Nuvation Bio Inc.	31,450	$178,636
5	INTS	Intensity Therapeutics, Inc.	26,006	$106,624

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$307,851	5,658	+2.9%	Shares	Sole	2026-07-09
2026-03-31	$235,895	5,500	-28.7%	Shares	Sole	2026-04-08
2025-12-31	$337,929	7,710	+0.1%	Shares	Sole	2026-02-05
2025-09-30	$318,010	7,700	0.0%	Shares	Sole	2025-10-17
2025-06-30	$339,416	7,700	0.0%	Shares	Sole	2025-07-09
2025-03-31	$284,284	7,700	0.0%	Shares	Sole	2025-04-15
2024-12-31	$256,410	7,700	—	Shares	Sole	2025-01-29
No filing history on record for this holder in this stock.